COMMUNIQUÉS West-GlobeNewswire

Shire plc : Director/PDMR Shareholding

01/03/2018 - 13:01

Director/PDMR Shareholding March 1, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of transactions by person discharging managerial responsibilities 1. Details of the person discharging managerial [...]

Antares Pharma Announces Receipt of Second Installment from Sale of Zomajet™ Needle-Free Delivery System

01/03/2018 - 13:00

EWING, N.J., March 01, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS ) (“Antares”) today announced that it has received $2.75 million from Ferring Pharmaceuticals (“Ferring”) in connection with the [...]

Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Corporate Update

01/03/2018 - 13:00

NEW YORK, March 01, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]

Sunesis Pharmaceuticals to Host Conference Call on March 8th to Discuss Fourth Quarter and Full-Year 2017 Financial Results and Recent Highlights

01/03/2018 - 13:00

SOUTH SAN FRANCISCO, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS ) today announced that it will host a conference call on Thursday, March 8th, 2018 at 1:30 p.m. Pacific Time to [...]

Codexis to Hold 2017 Fourth Quarter and Full Year Conference Call on March 8

01/03/2018 - 13:00

REDWOOD CITY, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS ), a leading protein engineering company, announces that it will report fourth quarter and full year 2017 financial results after [...]

Idera Pharmaceuticals Announces Launch of Global Phase 3 Trial Evaluating IMO-2125 in Combination with Ipilimumab for the Treatment of Anti-PD-1 Refractory Melanoma (ILLUMINATE 301)

01/03/2018 - 13:00

EXTON, Pa. and CAMBRIDGE, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA ), a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients [...]

Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2017 Results

01/03/2018 - 13:00

NASHVILLE, Tenn., March 01, 2018 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ: SGRY ) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the fourth quarter [...]

Revive Therapeutics and Ehave Enter Into Patient Research Data Collaboration Agreement for Medical Cannabis Liver Disease Program

01/03/2018 - 13:00

TORONTO, March 01, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (" Revive ") (TSX-V: RVV ) (OTCQB:RVVTF), a company focused on the research, development and commercialization of novel cannabinoid solutions, and [...]

Chimerix Announces Fourth Quarter and Full Year 2017 Financial Results

01/03/2018 - 13:00

- AdVance Data to be Presented at EBMT Annual Meeting - - Oral and IV BCV Programs Remain on Track - - Conference Call at 8:30 a.m. ET Today - DURHAM, N.C., March 01, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX ), a [...]

G1 Therapeutics to Present at Investor Conferences in March 2018

01/03/2018 - 13:00

RESEARCH TRIANGLE PARK, N.C., March 01, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a clinical-stage oncology company, today announced that Chief Executive Officer Mark Velleca, M.D., Ph.D., will [...]

Fibrogen Granted Fast Track Designation by U.S. FDA for Pamrevlumab Treatment of Patients with Locally Advanced Unresectable Pancreatic Cancer

01/03/2018 - 13:00

SAN FRANCISCO, March 01, 2018 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN ), a science-based biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track [...]

MPX Reports Q3 Fiscal 2018 Results

01/03/2018 - 13:00

TORONTO, March 01, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (the “ Corporation ” or “ MPX ”) (CSE:MPX) (OTCQB:MPXEF) reports financial results for its third quarter period ended December 31, 2017. (CDN$) 3 [...]

Paratek Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Remains on Track for Commercial Launch by First Quarter 2019

01/03/2018 - 13:00

Completed submission of NDAs for oral and intravenous omadacycline for the treatment of pneumonia and skin infections Expanded medical affairs and payer account management teams in readiness for discussions with [...]

Cannabis Wheaton Income Corp. and Sundial Sign Definitive Agreement for $7,000,000 in Debt Financing

01/03/2018 - 13:00

VANCOUVER, British Columbia, March 01, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (TSX-V: CBW ) ( "Cannabis Wheaton" or the " Company ") is pleased to announce that it has entered into a definitive agreement [...]

News Release: Proposed combination between Essilor and Luxottica approved without conditions by the European Commission

01/03/2018 - 12:47

Proposed combination between Essilor and Luxottica approved without conditions by the European Commission PDF Version of the news release Charenton-le-Pont, France and Milan, Italy ( March 1, 2018 ) - Essilor (Euronext [...]

Communiqué : La Commission Européenne autorise sans condition le projet de rapprochement entre Essilor et Luxottica

01/03/2018 - 12:47

La Commission Européenne autorise sans condition le projet de rapprochement entre Essilor et Luxottica Version PDF du communiqué Charenton-le-Pont, France et Milan, Italie (le 1 er mars 2018) - Essilor (Euronext Paris [...]

Loxo Oncology Reports Fourth Quarter and Year-End 2017 Financial Results

01/03/2018 - 12:45

– Larotrectinib Rolling NDA Submission on Track for Completion in March – – LOXO-292 Phase 1 Clinical Data Update Expected in First Half 2018 – STAMFORD, Conn., March 01, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. ( [...]

Edge Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results

01/03/2018 - 12:30

Interim Analysis from EG-1962 Phase 3 NEWTON 2 Study in Aneurysmal Subarachnoid Hemorrhage Expected by the End of April 2018 Full Top-Line Data from NEWTON 2 Study Expected in Late 2018 BERKELEY HEIGHTS, N.J., March 01 [...]

Wright Medical Group N.V. to Present at Barclays Global Healthcare Conference

01/03/2018 - 12:00

AMSTERDAM, The Netherlands, March 01, 2018 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ: WMGI ) announced today that it will present at Barclays Global Healthcare Conference on Thursday, March 15, 2018, at the [...]